Performance of a commercially available in-clinic ELISA for the detection of antibodies against Anaplasma phagocytophilum, Ehrlichia canis, and Borrelia burgdorferi and Dirofilaria immitis antigen in dogs.

OBJECTIVE To evaluate the sensitivity and specificity of a commercially available in-clinic ELISA for detection of heartworm infection and tick-borne diseases in dogs. SAMPLE POPULATION 846 serum, plasma, or blood samples obtained from dogs. PROCEDURES Samples were evaluated via the in-clinic ELISA to detect antibodies against Anaplasma phagocytophilum, Ehrlichia canis, and Borrelia burgdorferi and Dirofilaria immitis (heartworm) antigen. True infection or immunologic status of samples was assessed by use of results of necropsy, an antigen assay for D immitis, and immunofluorescence assay or western blot analysis for antibodies against B burgdorferi, E canis, and A phagocytophilum. RESULTS Sensitivity and specificity of the in-clinic ELISA for detection of heartworm antigen (99.2% and 100%, respectively), antibodies against B burgdorferi (98.8% and 100%, respectively), and antibodies against E canis (96.2% and 100%, respectively) were similar to results for a similar commercial ELISA. In samples obtained from dogs in the northeast and upper Midwest of the United States, sensitivity and specificity of the in-clinic ELISA for antibodies against Anaplasma spp were 99.1% and 100%, respectively, compared with results for an immunofluorescence assay. Samples from 2 dogs experimentally infected with the NY18 strain of A phagocytophilum were tested by use of the in-clinic ELISA, and antibodies against A phagocytophilum were detected by 8 days after inoculation. Antibodies against Anaplasma platys in experimentally infected dogs cross-reacted with the A phagocytophilum analyte. Coinfections were identified in several of the canine serum samples. CONCLUSIONS AND CLINICAL RELEVANCE The commercially available in-clinic ELISA could be used by veterinarians to screen dogs for heartworm infection and for exposure to tick-borne pathogens.

[1]  D. S. Adams,et al.  Evaluation of peptide- and recombinant protein-based assays for detection of anti-Ehrlichia ewingii antibodies in experimentally and naturally infected dogs. [corrected] , 2010, American journal of veterinary research.

[2]  E. Breitschwerdt,et al.  Experimental infection and co-infection of dogs with Anaplasma platys and Ehrlichia canis: hematologic, serologic and molecular findings , 2010, Parasites & Vectors.

[3]  E. Breitschwerdt,et al.  High prevalence of tick-borne pathogens in dogs from an Indian reservation in northeastern Arizona. , 2010, Vector borne and zoonotic diseases.

[4]  D. Otranto,et al.  Managing canine vector-borne diseases of zoonotic concern: part two. , 2009, Trends in parasitology.

[5]  C. L. Fritz.  Emerging tick-borne diseases. , 2009, The Veterinary clinics of North America. Small animal practice.

[6]  E. Breitschwerdt,et al.  Serological and molecular prevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, and Ehrlichia species in dogs from Minnesota. , 2008, Vector borne and zoonotic diseases.

[7]  S. Levy,et al.  Quantitative Measurement of C6 Antibody following Antibiotic Treatment of Borrelia burgdorferi Antibody-Positive Nonclinical Dogs , 2007, Clinical and Vaccine Immunology.

[8]  R. Hewer,et al.  Envelope-based HIV vaccine peptides as antigens in HIV-1 immunodiagnostics , 2007 .

[9]  I. Haro,et al.  Synthetic peptides for the immunodiagnosis of human diseases. , 2007, Current medicinal chemistry.

[10]  E. Breitschwerdt,et al.  Comparison of an indirect immunofluorescence assay, western blot analysis, and a commercially available ELISA for detection of Ehrlichia canis antibodies in canine sera. , 2006, American journal of veterinary research.

[11]  C. Atkins.  Comparison of results of three commercial heartworm antigen test kits in dogs with low heartworm burdens. , 2003, Journal of the American Veterinary Medical Association.

[12]  S. Telford,et al.  Transcript Heterogeneity of the p44 Multigene Family in a Human Granulocytic Ehrlichiosis Agent Transmitted by Ticks , 2002, Infection and Immunity.

[13]  A. Egenvall,et al.  Detection of granulocytic Ehrlichia species DNA by PCR in persistently infected dogs , 2000, Veterinary Record.

[14]  J. Bakken,et al.  Inter- and Intralaboratory Comparison ofEhrlichia equi and Human Granulocytic Ehrlichiosis (HGE) Agent Strains for Serodiagnosis of HGE by the Immunofluorescent-Antibody Test , 1999, Journal of Clinical Microbiology.

[15]  J. A. Comer,et al.  Serologic Testing for Human Granulocytic Ehrlichiosis at a National Referral Center , 1999, Journal of Clinical Microbiology.

[16]  J. A. Comer,et al.  An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis , 1997, Journal of clinical microbiology.

[17]  Å. Hedhammar,et al.  Clinical features and serology of 14 dogs affected by granulocytic ehrlichiosis in Sweden , 1997, Veterinary Record.

[18]  J. Dumler,et al.  Direct cultivation of the causative agent of human granulocytic ehrlichiosis. , 1996, The New England journal of medicine.

[19]  J. Bakken,et al.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease , 1994, Journal of clinical microbiology.

[20]  J. Anderson,et al.  Serologic evidence of canine and equine ehrlichiosis in northeastern United States , 1993, Journal of clinical microbiology.

[21]  H. W. Casey,et al.  Evaluation of Rhipicephalus sanguineus as a potential biologic vector of Ehrlichia platys. , 1991, American journal of veterinary research.

[22]  Y. Rikihisa,et al.  Cross-reacting antigens between Neorickettsia helminthoeca and Ehrlichia species, shown by immunofluorescence and Western immunoblotting , 1991, Journal of clinical microbiology.

[23]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[24]  C. Genchi,et al.  Heartworm disease in animals and humans. , 2008, Advances in parasitology.

[25]  R. Chandrashekar,et al.  Serologic Diagnosis of Equine Borreliosis: Evaluation of an In-Clinic Enzyme-Linked Immunosorbent Assay (SNAP ® 4Dx ® ) , 2008 .

[26]  S. Levy.  Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection. , 2002, Veterinary therapeutics : research in applied veterinary medicine.

[27]  E. Breitschwerdt,et al.  Seroprevalence of Ehrlichia canis, Ehrlichia equi, and Ehrlichia risticii in sick dogs from North Carolina and Virginia. , 2000, Journal of veterinary internal medicine.

[28]  M. Ristic,et al.  Rickettsial and chlamydial diseases of domestic animals , 1993 .

[29]  M. Nyindo,et al.  Immune response of ponies to experimental infection with Ehrlichia equi. , 1978, American journal of veterinary research.